- Report
- December 2021
- 55 Pages
Global
- Report
- May 2022
- 61 Pages
Global
- Report
- November 2023
- 160 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- April 2023
- 300 Pages
Global
From €3197EUR$3,350USD£2,679GBP
- Report
- November 2021
- 106 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- June 2021
- 110 Pages
Global
From €6676EUR$6,995USD£5,593GBP
- Report
- May 2023
- 128 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- May 2022
- 296 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Book
- January 2022
- 504 Pages
- Report
- December 2022
- 235 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Book
- September 2023
- 384 Pages
- Book
- October 2020
- 432 Pages
- Book
- July 2023
- 512 Pages
- Book
- July 2023
- 512 Pages
- Book
- October 2022
- 592 Pages
- Book
- June 2022
- 336 Pages

The gut microbiome market is a rapidly emerging sector within the biotechnology industry, focusing on the diverse community of microorganisms that reside in the human gastrointestinal tract. This market encompasses a variety of applications that include therapeutic products, diagnostics, and probiotics aimed at harnessing and modulating the gut flora for improved health outcomes. Biotechnology companies in this space are engaged in research and development activities aimed at understanding the complex interactions between these microorganisms and the human host. The scientific advances in genomics, metabolomics, and bioinformatics have been crucial in driving innovations in this market, as they enable a deeper understanding of the microbiome's role in health and disease. The sector is responding to a broad range of health issues, including gastrointestinal disorders, immune system function, and metabolic diseases. The increasing consumer interest in personalized medicine and nutrition further fuels the growth and diversification of the gut microbiome market.
Some notable companies in the gut microbiome market include Seed Health, Vedanta Biosciences, Finch Therapeutics, Seres Therapeutics, and uBiome. These enterprises are at the forefront of developing novel microbiome-based treatments and diagnostics, each aiming to translate the complex interactions of the gut microbiome into tangible health solutions. Show Less Read more